東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Exploring drug delivery to the perit...

Shegokar, Ranjita.

FindBook

Google Book

Amazon

博客來

Exploring drug delivery to the peritoneum

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Exploring drug delivery to the peritoneum/ edited by Ranjita Shegokar.
其他作者:	Shegokar, Ranjita.
出版者:	Cham :Springer International Publishing : : 2023.,
面頁冊數:	x, 242 p. :illustrations (chiefly color), digital ;24 cm.
內容註:	Chapter 1: Peritoneal Organ-Anatomical and Physiological Considerations -- Chapter 2: drug delivery platforms for intra-peritoneal delivery focusing primarily on need, delivery systems, clinical progress, market and regulatory aspects -- Chapter 3: Liposomes and Lipid Nanoparticles as Peritoneal Drug Delivery Systems -- Chapter 4: Nano and micro/medicines for intraperitoneal therapy in ovarian cancer: critical overview and focus on pharmaceutical manufacturing under cGMP -- Chapter 5: Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC): Promising Strides from India -- Chapter 6: HIPEC: Concept and Fundamentals in Colorectal Cáncer Peritoneal Mestatasis Treatment -- Chapter 7: Peritoneal Implants and Drug Delivery -- Chapter 8: Importance of Computational Models in Development of Intrapertitoneal Administration based Drug Delivery Systems for Solid Tumors -- Chapter 9: Drug Delivery Systems for peritonium : current status and Future perspectives -- Chapter 10: Exploring the Intraperitoneal Route in a New Way for Preclinical Testing.
Contained By:	Springer Nature eBook
標題:	Drug delivery systems. -
電子資源:	https://doi.org/10.1007/978-3-031-31694-4
ISBN:	9783031316944

Exploring drug delivery to the peritoneum
Exploring drug delivery to the peritoneum[electronic resource] /edited by Ranjita Shegokar. - Cham :Springer International Publishing :2023. - x, 242 p. :illustrations (chiefly color), digital ;24 cm.

Chapter 1: Peritoneal Organ-Anatomical and Physiological Considerations -- Chapter 2: drug delivery platforms for intra-peritoneal delivery focusing primarily on need, delivery systems, clinical progress, market and regulatory aspects -- Chapter 3: Liposomes and Lipid Nanoparticles as Peritoneal Drug Delivery Systems -- Chapter 4: Nano and micro/medicines for intraperitoneal therapy in ovarian cancer: critical overview and focus on pharmaceutical manufacturing under cGMP -- Chapter 5: Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC): Promising Strides from India -- Chapter 6: HIPEC: Concept and Fundamentals in Colorectal Cáncer Peritoneal Mestatasis Treatment -- Chapter 7: Peritoneal Implants and Drug Delivery -- Chapter 8: Importance of Computational Models in Development of Intrapertitoneal Administration based Drug Delivery Systems for Solid Tumors -- Chapter 9: Drug Delivery Systems for peritonium : current status and Future perspectives -- Chapter 10: Exploring the Intraperitoneal Route in a New Way for Preclinical Testing.

ISBN: 9783031316944

Standard No.: 10.1007/978-3-031-31694-4doiSubjects--Topical Terms:

657987
Drug delivery systems.

LC Class. No.: RS199.5

Dewey Class. No.: 615.6

Exploring drug delivery to the peritoneum
LDR:02012nmm a2200313 a 4500 001 2336353
003 DE-He213
005 20231130151828.0
006 m d
007 cr nn 008maaau
008 240402s2023 sz s 0 eng d
020 $a 9783031316944 $q (electronic bk.)
020 $a 9783031316937 $q (paper)
024 7 $a 10.1007/978-3-031-31694-4 $2 doi
035 $a 978-3-031-31694-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RS199.5
072 7 $a TCB $2 bicssc
072 7 $a SCI010000 $2 bisacsh
072 7 $a TCB $2 thema
082 0 4 $a 615.6 $2 23
090 $a RS199.5 $b .E96 2023
245 0 0 $a Exploring drug delivery to the peritoneum $h [electronic resource] / $c edited by Ranjita Shegokar.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a x, 242 p. : $b illustrations (chiefly color), digital ; $c 24 cm.
505 0 $a Chapter 1: Peritoneal Organ-Anatomical and Physiological Considerations -- Chapter 2: drug delivery platforms for intra-peritoneal delivery focusing primarily on need, delivery systems, clinical progress, market and regulatory aspects -- Chapter 3: Liposomes and Lipid Nanoparticles as Peritoneal Drug Delivery Systems -- Chapter 4: Nano and micro/medicines for intraperitoneal therapy in ovarian cancer: critical overview and focus on pharmaceutical manufacturing under cGMP -- Chapter 5: Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC): Promising Strides from India -- Chapter 6: HIPEC: Concept and Fundamentals in Colorectal Cáncer Peritoneal Mestatasis Treatment -- Chapter 7: Peritoneal Implants and Drug Delivery -- Chapter 8: Importance of Computational Models in Development of Intrapertitoneal Administration based Drug Delivery Systems for Solid Tumors -- Chapter 9: Drug Delivery Systems for peritonium : current status and Future perspectives -- Chapter 10: Exploring the Intraperitoneal Route in a New Way for Preclinical Testing.
650 0 $a Drug delivery systems. $3 657987
650 0 $a Peritoneum. $3 3669391
650 1 4 $a Drug Delivery. $3 3531319
650 2 4 $a Pharmacology. $3 634543
650 2 4 $a Pharmacy. $3 636101
650 2 4 $a Pharmaceutics. $3 3538434
650 2 4 $a Drug Safety and Pharmacovigilance. $3 2108855
650 2 4 $a Biomedical Research. $3 851895
700 1 $a Shegokar, Ranjita. $3 3269671
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-31694-4
950 $a Medicine (SpringerNature-11650)